CD38 and neuroblastoma: Interestingly, our study also described as CD38+ and CD73+ EVs in the BM negatively affected the event-free survival of NB patients, confirming their critical impact on the immune-privileged microenvironment of neoplastic cells, that, in turn, support the metastatic spread of NB cells [71].